Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Last month, the UK Government published its long-awaited 10-Year Health Plan, with one of its three key shifts being the move ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

A landmark ruling from the Supreme Court of Appeal means specially trained pharmacists will soon be allowed to dispense antiretrovirals without a doctor's script. Pharmacists with the required ...

Dr Joel Steingo of TB HIV Care says Lenacapavir could be a breakthrough in reducing infections, especially at a time when ...

Intracellular living therapeutics convert cellular signals into coordinated healing programs Get small and look inside. I ...

OpenAI, Founders Fund and Lux Capital have invested in Valthos, a startup using AI to try to prevent AI-enabled destruction.

HIV prevention drug Lenacapavir, which has been tested in South Africa during clinical trials, will be made available in the country in 2026 for high-risk groups.

MTN Group Fintech has made history by winning the first Regional Platform Business Award at MTN’s prestigious Y’ello Care ...

The commission accepts inquiries year round from those expressing interest in serving in this volunteer capacity.

Health is the foundation of wealth and development. No nation can rise above the health of its people. As Mahatma Gandhi once ...